NASDAQ · Stocky rates: Avoid

ADPT

$24.35 ▲ +3.18% as of 7 Aug, 14:53

Stocky turns companies like ADPT into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
23
/ 100
Avoid

What Stocky thinks

Avoid. ADPT's Value Compounder Score of 16/100 signals weak fundamental economics, compounded by material supplier dependency: Illumina controls sole or limited supply of NextSeq and NovaSeq sequencers plus maintenance, creating structural fragility. Leadership Alignment at 53/100 adds execution risk without offsetting operational moats.

Compounder Score
16/100
Business quality — profitability, growth, capital efficiency.
Vulnerability
25/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
16/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for ADPT:

23
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 23/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

25
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

ADPT (ADPT) — frequently asked

Is ADPT (ADPT) a good investment right now?

Stocky rates ADPT (ADPT) at 23/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. ADPT's Value Compounder Score of 16/100 signals weak fundamental economics, compounded by material supplier dependency: Illumina controls sole or limited supply of NextSeq and NovaSeq sequencers plus maintenance, creating structu

What is ADPT's Stocky Verdict?

ADPT's current Stocky Verdict is 23/100, placing it in the "Avoid" band. This composite combines a 16/100 Compounder score, Leadership, Moat rating, and analyst signal.

Does ADPT have a competitive moat?

Stocky hasn't finalised a Moat Score for ADPT yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is ADPT's leadership aligned with shareholders?

Leadership Alignment for ADPT is under analysis. Stocky scores founder tenure, insider ownership, CEO compensation multiple-of-salary, and long-term shareholder value creation.

What are the biggest risks to ADPT?

ADPT's Vulnerability Profile scores 25/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to ADPT.

This is just the surface. See the whole picture on ADPT.

Sign up free and unlock the full analysis on ADPT — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering ADPT — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for ADPT.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how ADPT changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to ADPT?" · "Is ADPT overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
23
/ 100 · Avoid

See ADPT the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in ADPT would be worth today.
Practice portfolio
Buy ADPT with virtual money and track it — zero risk.
Free · no real money · learn by doing Open ADPT in Stocky →

Or jump straight to the interactive dashboard for ADPT in the app.